VanDerGinst Law is currently invesigating complaints stemming from the use of the drug, Risperdal. Risperdal® is an antipsychotic drug prescribed to treat certain mental and mood disorders, such as schizophrenia, bipolar disorder, and irritability associated with autism. Research has shown that Risperdal can cause gynecomastia—the development of abnormally large male breasts—in young boys and adolescents, which often requires surgery to correct. Along with the development of abnormally large male breasts, lactation may occur. Risperdal may also cause tardive dyskinesia, a neurological disorder that causes uncontrolled body movements.
If you or your child took Risperdal and suffered from gynecomastia, tardive dyskinesia or lactation, you may be entitled to compensation for medical bills, pain and suffering, and other expenses.
Contact VanDerGinst Law to see if you have a case— we want to help.
Risperdal® and Gynecomastia
In January 2012, Bloomberg reported that Johnson & Johnson, the manufacturer of Risperdal, was marketing the drug to doctors working with troubled children for uses not approved by the FDA in 2004.
Research has shown the risks Risperdal can pose to children. The largest study on the side effects of the drug in adolescents and children showed hormonal changes in male patients that led to the development of abnormally large male breasts, or gynecomastia. Researchers concluded that Risperdal should be administered to children and adolescents with caution.
Protect Your Rights
We are here to help if you or your child took Risperdal before 2007 and suffered from gynecomastia, tardive dyskinesia or developed lactation. Call us at 866-788-LAWS (5297) or e-mail us at info@VLaw.com.
Risperdal® is a registered trademark of Johnson & Johnson, and is used here only to identify the product in question.
VanDerGinst Law is not associated with, sponsored by, or affiliated with Bloomberg L.P.; Johnson & Johnson; the Journal of Clinical Psychopharmacology; the National Center for Biotechnology Information; or the U.S. Food and Drug Administration.